Midazolam and Pemetrexed drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Midazolam (midazolam) and Pemetrexed (pemetrexed). Common drug interactions include pyrexia among females and interstitial lung disease among males.

The phase IV clinical study analyzes what interactions people have when they take Midazolam and Pemetrexed. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Midazolam?

Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.

What is Pemetrexed?

Pemetrexed has active ingredients of pemetrexed. eHealthMe is studying from 17,491 Pemetrexed users. Check the latest studies of Pemetrexed.



On Jul, 18, 2026

51 people who take Midazolam and Pemetrexed together, and have interactions are studied.

Midazolam and Pemetrexed drug interactions.

What are the common drug interactions of Midazolam and Pemetrexed, by gender? *:

female:

  1. Pyrexia (fever)
  2. Diarrhoea
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Vulvovaginal mycotic infection (vulvovaginal fungal infection)
  5. Oesophagitis (inflammation of oesophagus)
  6. Abdominal pain
  7. Cough
  8. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  9. Anaemia (lack of blood)
  10. Death

male:

  1. Interstitial lung disease
  2. Respiratory distress (difficulty in breathing)
  3. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  4. Nephropathy toxic (damage to kidney due to toxins)
  5. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  6. Acute respiratory distress syndrome
  7. Colitis (inflammation of colon)
  8. Confusional state
  9. Hepatic failure (liver failure)
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)

What are the common drug interactions of Midazolam and Pemetrexed, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Colitis (inflammation of colon)
  2. Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)

50-59:

  1. Oesophagitis (inflammation of oesophagus)
  2. Bronchostenosis (narrowing of a bronchial tube by scarring or other stricture)
  3. Pneumonia
  4. Colitis (inflammation of colon)
  5. Confusional state
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  7. Skin toxicity (skin damage due to toxin/poison)
  8. Syncope (loss of consciousness with an inability to maintain postural tone)

60+:

  1. Pyrexia (fever)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Death
  4. Pneumonia
  5. Platelet count decreased
  6. Myocarditis (inflammation of heart muscle myocardium)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Cerebral infarction (less blood supply to brain resulting tissue damage)
  9. Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
  10. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 16 people, 31.37%
  2. Lung Adenocarcinoma (a form of non-small cell lung cancer): 13 people, 25.49%
  3. Neoplasm Malignant (cancer tumour): 12 people, 23.53%
  4. Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 10 people, 19.61%
  5. Cough: 10 people, 19.61%
  6. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 10 people, 19.61%
  7. Nausea (feeling of having an urge to vomit): 8 people, 15.69%
  8. Infection: 8 people, 15.69%
  9. Pain: 8 people, 15.69%
  10. Cerebral Infarction (less blood supply to brain resulting tissue damage): 8 people, 15.69%

* Approximation only. Some reports may have incomplete information.

Do you take Midazolam and Pemetrexed?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Midazolam and Pemetrexed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Midazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pemetrexed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Midazolam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pemetrexed and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on midazolam and pemetrexed (the active ingredients of Midazolam and Pemetrexed, respectively), and Midazolam and Pemetrexed (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: